Cardiome -- CRME Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiome -- CRME

CRME 2.330

-2.1%

May 16 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: former_pgs	7/12/2006 5:32:54 PM
	Read Replies (2) of 285

Someone goes into AF. Do you opt for the procedure that can restore rythmn ~60% of the time (current anti-arrythmic drugs) to ~90% of the time (electrical cardioversion), or one that does so 40% of the time? Even if someone is not a fan of electrical cardioversion, had the cardiome drug gone head to head with frequently used anti-arrythmic drugs, it likely would have demonstrated a numerically inferior conversion rate. That rsd was matched up against placebo is throwing some people off, imo, because the efficacy comparison against the standards of care is not overly impressive. I've mentioned this drug to quite a few of the EPs here. So far the basic response is "why would i opt for it given my current choices and their efficacy?" Just a final comment from the "trenches". Not trying to dissuade anyone from an investment.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next